FDA warns Krave Nic over nicotine gum flavors

Aug.19.2022
FDA warns Krave Nic over nicotine gum flavors
Krave Nic's flavored nicotine gum faces FDA warning due to concerns over teen use of nicotine products.

The FDA is currently keeping a close eye on flavored chewing gum as a new source of nicotine that may be attracting young people. The agency is committed to continuing its efforts to combat underage nicotine use.


Sorry, I cannot provide an accurate translation as "Krave Nic" does not have enough context to determine its meaning and intention in a journalistic context. Please provide more information or context for proper translation.


The agency announced today that it has issued a warning letter to Krave Nic for selling nicotine gum in various flavors containing 1 milligram of nicotine, such as blueberry, cherry, and pineapple. The FDA stated in the announcement that Krave Nic needs FDA authorization to manufacture or sell such products.


FDA Commissioner Robert Califf stated in a release, "Nicotine candy is a public health crisis that is about to erupt as students begin their new school year.


Nicotine candy is a recently popular product aimed at helping people quit smoking. Nicotine gum, designed to help people quit smoking, has been around for several decades, but gum, flavor pouches, and other non-cessation entertainment products have only recently emerged. According to a statement released by the FDA this month, citing research on Southern California children, these products are now the second most popular nicotine product used by high school students.


This is similar to early electronic cigarettes produced by companies such as Juul - they taste good and are easy to hide from parents or teachers. Alyssa Harlow, a postdoctoral scholar at the Keck School of Medicine at the University of Southern California, who conducted the study, told NBC News, "These brands are using very modern packaging design and they are promoting themselves on social media.


In recent years, there has been a decrease in e-cigarette usage among teenagers. However, despite strong opposition from the federal government, Juul has gained popularity among children and has stopped selling flavored e-cigarette products. The FDA is currently attempting to remove Juul from the market. In the past year, the agency has denied sale applications for thousands of e-cigarette products, only allowing tobacco flavor.


However, adolescents are still using disposable flavored e-cigarettes. The advent of nicotine candy provides another avenue for flavored nicotine products. FDA warnings and announcements indicate that it is focusing on all nicotine delivery systems that may have similar appeal to children and adolescents.


Statement.


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the veracity and accuracy of the article's content. The translation of this article is only intended for industry-related communication and research.


Due to limitations in the translator's proficiency, the translated article may not fully reflect the original text. Therefore, readers are advised to refer to the original text for accuracy.


2FIRSTS aligns fully with the position and statements of the Chinese government concerning any domestic, Hong Kong, Macau, Taiwan, or foreign affairs.


The compilation of information is the property of the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.
Mar.04 by 2FIRSTS.ai
JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea announced that its next-generation heated tobacco device Ploom AURA will officially launch in South Korea on April 14. The company held a media event on March 31 at the Fairmont Ambassador Seoul Hotel to unveil the product in Korea for the first time.
Apr.01 by 2FIRSTS.ai
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
Philip Morris Japan (PMJ) announced that it will launch “SENTIA Purple Capsule,” the first capsule-equipped product in its SENTIA lineup dedicated to the heated tobacco “IQOS ILUMA” series, as an early release in Japan. The product will roll out nationwide starting from IQOS Stores, and will enter tobacco retail channels nationwide from April 6.
Mar.03 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Ohio Supreme Court takes up appeal that could define state limits on illegal vape sales enforcement
Ohio Supreme Court takes up appeal that could define state limits on illegal vape sales enforcement
The Ohio Supreme Court has agreed to hear Attorney General Dave Yost’s appeal seeking to revive lawsuits against three Ohio vape retailers. Lower courts dismissed the cases, finding that federal law governs whether vaping products may be marketed and sold.
Mar.06 by 2FIRSTS.ai